| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonic Neoplasms | 33 | 2020 | 2542 | 3.720 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 22 | 2020 | 379 | 3.690 |
Why?
|
| Adenoma | 17 | 2023 | 2168 | 2.080 |
Why?
|
| Colorectal Neoplasms | 33 | 2024 | 6754 | 2.010 |
Why?
|
| Adenomatous Polyposis Coli | 12 | 2021 | 224 | 1.950 |
Why?
|
| Retinal Dystrophies | 6 | 2022 | 58 | 1.920 |
Why?
|
| Microsatellite Instability | 12 | 2019 | 678 | 1.910 |
Why?
|
| cis-trans-Isomerases | 12 | 2022 | 44 | 1.660 |
Why?
|
| Stomach Neoplasms | 11 | 2020 | 1327 | 1.610 |
Why?
|
| Colonoscopy | 17 | 2024 | 1365 | 1.380 |
Why?
|
| Gene Expression Regulation, Neoplastic | 20 | 2019 | 8425 | 1.360 |
Why?
|
| Neoplastic Syndromes, Hereditary | 7 | 2019 | 241 | 1.330 |
Why?
|
| Colonic Polyps | 8 | 2023 | 542 | 1.320 |
Why?
|
| Precancerous Conditions | 4 | 2024 | 971 | 1.210 |
Why?
|
| Genetic Testing | 13 | 2020 | 3439 | 1.170 |
Why?
|
| Germ-Line Mutation | 10 | 2019 | 1786 | 1.040 |
Why?
|
| ras Proteins | 5 | 2014 | 1060 | 1.000 |
Why?
|
| Carcinoma, Signet Ring Cell | 2 | 2019 | 83 | 0.970 |
Why?
|
| Pancreatic Neoplasms | 19 | 2022 | 5249 | 0.930 |
Why?
|
| Early Detection of Cancer | 8 | 2024 | 3070 | 0.880 |
Why?
|
| Adenomatous Polyps | 3 | 2014 | 107 | 0.870 |
Why?
|
| Neuroendocrine Tumors | 7 | 2017 | 594 | 0.850 |
Why?
|
| Pupil | 3 | 2013 | 149 | 0.840 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2016 | 1114 | 0.830 |
Why?
|
| Mass Screening | 8 | 2024 | 5238 | 0.820 |
Why?
|
| Carcinoid Tumor | 3 | 2015 | 235 | 0.820 |
Why?
|
| Intestinal Neoplasms | 6 | 2017 | 319 | 0.810 |
Why?
|
| Neovascularization, Pathologic | 11 | 2010 | 2633 | 0.800 |
Why?
|
| DNA Mismatch Repair | 7 | 2018 | 424 | 0.770 |
Why?
|
| Genes, ras | 5 | 2010 | 691 | 0.750 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2010 | 627 | 0.750 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2019 | 4553 | 0.740 |
Why?
|
| Choroideremia | 5 | 2022 | 25 | 0.720 |
Why?
|
| Leber Congenital Amaurosis | 4 | 2016 | 33 | 0.680 |
Why?
|
| Genetic Vectors | 16 | 2022 | 3420 | 0.680 |
Why?
|
| Dependovirus | 12 | 2022 | 706 | 0.670 |
Why?
|
| Eye Diseases, Hereditary | 2 | 2018 | 117 | 0.660 |
Why?
|
| Cell Hypoxia | 5 | 2013 | 675 | 0.630 |
Why?
|
| Proto-Oncogene Proteins B-raf | 5 | 2017 | 2028 | 0.610 |
Why?
|
| Adenocarcinoma | 12 | 2022 | 6347 | 0.600 |
Why?
|
| Carcinoma, Papillary | 3 | 2007 | 781 | 0.600 |
Why?
|
| Gastritis | 1 | 2019 | 191 | 0.600 |
Why?
|
| Visual Acuity | 8 | 2021 | 2520 | 0.590 |
Why?
|
| Cyclin D1 | 3 | 2005 | 462 | 0.590 |
Why?
|
| Cysts | 1 | 2022 | 676 | 0.580 |
Why?
|
| Fluorouracil | 6 | 2018 | 1615 | 0.580 |
Why?
|
| Mutation | 30 | 2021 | 29717 | 0.580 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 987 | 0.570 |
Why?
|
| Visually Impaired Persons | 1 | 2017 | 81 | 0.570 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2022 | 1631 | 0.570 |
Why?
|
| Visual Fields | 5 | 2021 | 1049 | 0.550 |
Why?
|
| Gene Transfer Techniques | 5 | 2015 | 1224 | 0.550 |
Why?
|
| Eye Proteins | 6 | 2011 | 644 | 0.540 |
Why?
|
| Helicobacter Infections | 1 | 2019 | 385 | 0.530 |
Why?
|
| Retinal Diseases | 1 | 2021 | 683 | 0.520 |
Why?
|
| Common Bile Duct Neoplasms | 2 | 2014 | 111 | 0.520 |
Why?
|
| Ampulla of Vater | 2 | 2014 | 141 | 0.510 |
Why?
|
| Gastrointestinal Hemorrhage | 6 | 2016 | 1130 | 0.510 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2016 | 640 | 0.500 |
Why?
|
| Carrier Proteins | 14 | 2015 | 5019 | 0.490 |
Why?
|
| Cadherins | 6 | 2012 | 906 | 0.490 |
Why?
|
| Gastrointestinal Neoplasms | 5 | 2008 | 987 | 0.490 |
Why?
|
| Cecal Neoplasms | 1 | 2014 | 29 | 0.490 |
Why?
|
| Chitosan | 1 | 2015 | 140 | 0.460 |
Why?
|
| Adrenomedullin | 1 | 2013 | 87 | 0.460 |
Why?
|
| Endoscopy, Digestive System | 2 | 2014 | 345 | 0.460 |
Why?
|
| Humans | 180 | 2024 | 742088 | 0.450 |
Why?
|
| MutS Homolog 2 Protein | 4 | 2019 | 200 | 0.450 |
Why?
|
| Rectal Neoplasms | 8 | 2011 | 1195 | 0.450 |
Why?
|
| Vascular Endothelial Growth Factor A | 13 | 2010 | 3502 | 0.450 |
Why?
|
| Reflex, Pupillary | 2 | 2012 | 61 | 0.440 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2015 | 437 | 0.440 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2013 | 1097 | 0.430 |
Why?
|
| Hypoxia-Inducible Factor 1 | 3 | 2009 | 198 | 0.420 |
Why?
|
| Integrases | 1 | 2015 | 533 | 0.420 |
Why?
|
| Loss of Heterozygosity | 8 | 2010 | 678 | 0.420 |
Why?
|
| Immunohistochemistry | 14 | 2018 | 11363 | 0.420 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2012 | 162 | 0.400 |
Why?
|
| Chromosomal Instability | 2 | 2010 | 184 | 0.400 |
Why?
|
| DNA Glycosylases | 3 | 2011 | 128 | 0.400 |
Why?
|
| Promoter Regions, Genetic | 13 | 2017 | 5867 | 0.400 |
Why?
|
| Endometrial Neoplasms | 2 | 2018 | 1351 | 0.380 |
Why?
|
| Cyclins | 6 | 2013 | 601 | 0.380 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2013 | 2940 | 0.380 |
Why?
|
| CD-ROM | 1 | 2010 | 24 | 0.370 |
Why?
|
| Plasmids | 2 | 2015 | 2305 | 0.370 |
Why?
|
| DNA Methylation | 5 | 2019 | 4282 | 0.360 |
Why?
|
| Optic Neuritis | 1 | 2012 | 166 | 0.360 |
Why?
|
| Blindness | 5 | 2016 | 615 | 0.350 |
Why?
|
| Feces | 6 | 2020 | 1394 | 0.350 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 6 | 2014 | 1683 | 0.350 |
Why?
|
| Thyroid Neoplasms | 3 | 2007 | 2274 | 0.350 |
Why?
|
| DNA-Binding Proteins | 11 | 2019 | 9639 | 0.340 |
Why?
|
| Optic Nerve | 1 | 2012 | 548 | 0.330 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2014 | 2915 | 0.320 |
Why?
|
| Tumor Microenvironment | 3 | 2020 | 3564 | 0.310 |
Why?
|
| Diverticulum | 2 | 2020 | 136 | 0.310 |
Why?
|
| Adult | 67 | 2024 | 213712 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2008 | 286 | 0.300 |
Why?
|
| Female | 92 | 2021 | 379592 | 0.300 |
Why?
|
| Genetic Markers | 6 | 2014 | 2633 | 0.300 |
Why?
|
| Male | 89 | 2021 | 349538 | 0.300 |
Why?
|
| Middle Aged | 65 | 2022 | 213127 | 0.300 |
Why?
|
| DNA, Neoplasm | 3 | 2018 | 1758 | 0.300 |
Why?
|
| Base Pair Mismatch | 3 | 2005 | 97 | 0.290 |
Why?
|
| Wnt Proteins | 3 | 2005 | 721 | 0.290 |
Why?
|
| Colon | 4 | 2016 | 1773 | 0.290 |
Why?
|
| Light | 2 | 2012 | 1374 | 0.280 |
Why?
|
| Mesoderm | 1 | 2009 | 686 | 0.280 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2012 | 834 | 0.280 |
Why?
|
| Genes, APC | 2 | 2003 | 159 | 0.270 |
Why?
|
| Gastrectomy | 4 | 2019 | 652 | 0.270 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2014 | 2938 | 0.270 |
Why?
|
| Aged | 53 | 2021 | 162944 | 0.260 |
Why?
|
| Nuclear Proteins | 4 | 2014 | 5851 | 0.260 |
Why?
|
| Parathyroid Neoplasms | 2 | 2004 | 245 | 0.260 |
Why?
|
| Retinal Degeneration | 1 | 2009 | 414 | 0.260 |
Why?
|
| Gastroscopy | 2 | 2019 | 206 | 0.250 |
Why?
|
| Homeodomain Proteins | 4 | 2019 | 2417 | 0.250 |
Why?
|
| Cell Line, Tumor | 13 | 2014 | 16665 | 0.250 |
Why?
|
| Patient Compliance | 2 | 2015 | 2680 | 0.250 |
Why?
|
| Islets of Langerhans | 3 | 2005 | 1351 | 0.250 |
Why?
|
| Genetic Association Studies | 4 | 2019 | 2699 | 0.250 |
Why?
|
| Retina | 9 | 2022 | 2611 | 0.240 |
Why?
|
| Thrombospondin 1 | 1 | 2005 | 250 | 0.240 |
Why?
|
| Phosphoproteins | 6 | 2013 | 2440 | 0.240 |
Why?
|
| Eye Diseases | 1 | 2009 | 670 | 0.230 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2007 | 324 | 0.230 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 430 | 0.220 |
Why?
|
| DNA Repair Enzymes | 2 | 2016 | 349 | 0.220 |
Why?
|
| Stomach | 1 | 2007 | 697 | 0.220 |
Why?
|
| Interleukin-8 | 1 | 2005 | 689 | 0.210 |
Why?
|
| Signal Transduction | 13 | 2021 | 23387 | 0.210 |
Why?
|
| Carcinoma | 4 | 2020 | 2374 | 0.210 |
Why?
|
| DNA Repair | 3 | 2003 | 2042 | 0.210 |
Why?
|
| Transfection | 6 | 2016 | 5892 | 0.210 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2022 | 101 | 0.210 |
Why?
|
| Electroretinography | 4 | 2018 | 509 | 0.210 |
Why?
|
| Cell Proliferation | 7 | 2012 | 10472 | 0.200 |
Why?
|
| Duodenal Neoplasms | 2 | 2014 | 106 | 0.200 |
Why?
|
| Epithelial Cells | 4 | 2010 | 3678 | 0.200 |
Why?
|
| Aged, 80 and over | 26 | 2020 | 57683 | 0.200 |
Why?
|
| Transcription Factors | 7 | 2021 | 12164 | 0.200 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 12071 | 0.200 |
Why?
|
| Mice, Nude | 5 | 2013 | 3689 | 0.190 |
Why?
|
| Retinal Perforations | 1 | 2022 | 131 | 0.190 |
Why?
|
| Polyendocrinopathies, Autoimmune | 1 | 2021 | 55 | 0.190 |
Why?
|
| Adenosine Triphosphatases | 2 | 2016 | 836 | 0.190 |
Why?
|
| Injections, Intraocular | 3 | 2021 | 30 | 0.190 |
Why?
|
| Adolescent | 28 | 2021 | 85649 | 0.190 |
Why?
|
| Vision, Ocular | 3 | 2022 | 463 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2019 | 17400 | 0.180 |
Why?
|
| Genotype | 8 | 2015 | 12946 | 0.180 |
Why?
|
| Visual Field Tests | 2 | 2019 | 383 | 0.180 |
Why?
|
| Thyroid Gland | 1 | 2006 | 1172 | 0.180 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 2275 | 0.170 |
Why?
|
| Eye | 3 | 2015 | 728 | 0.170 |
Why?
|
| Gastrins | 2 | 1998 | 81 | 0.170 |
Why?
|
| Heterozygote | 7 | 2021 | 2790 | 0.170 |
Why?
|
| Retinal Cone Photoreceptor Cells | 3 | 2016 | 177 | 0.170 |
Why?
|
| Endothelial Growth Factors | 1 | 2001 | 694 | 0.170 |
Why?
|
| Codon, Nonsense | 2 | 2014 | 281 | 0.160 |
Why?
|
| Endosonography | 1 | 2022 | 610 | 0.160 |
Why?
|
| Colitis, Microscopic | 1 | 2019 | 77 | 0.160 |
Why?
|
| Chromosome Mapping | 4 | 2007 | 4742 | 0.160 |
Why?
|
| Lymphokines | 1 | 2001 | 949 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 18 | 5 | 2007 | 245 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 4 | 2022 | 2637 | 0.160 |
Why?
|
| Adenoma, Islet Cell | 1 | 1997 | 82 | 0.160 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4440 | 0.160 |
Why?
|
| Glycine | 1 | 2021 | 671 | 0.160 |
Why?
|
| Up-Regulation | 5 | 2010 | 4211 | 0.150 |
Why?
|
| Peutz-Jeghers Syndrome | 2 | 2011 | 50 | 0.150 |
Why?
|
| Animals | 37 | 2022 | 168561 | 0.150 |
Why?
|
| Young Adult | 14 | 2022 | 56350 | 0.150 |
Why?
|
| Genes, Retinoblastoma | 1 | 1997 | 136 | 0.150 |
Why?
|
| Dinoprostone | 1 | 2020 | 600 | 0.150 |
Why?
|
| Angiogenesis Inhibitors | 4 | 2009 | 2038 | 0.150 |
Why?
|
| Aspirin | 3 | 2020 | 3278 | 0.150 |
Why?
|
| Probiotics | 1 | 2021 | 351 | 0.150 |
Why?
|
| Scleroderma, Systemic | 1 | 2021 | 313 | 0.150 |
Why?
|
| Genetic Counseling | 5 | 2010 | 600 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 625 | 0.150 |
Why?
|
| Caco-2 Cells | 3 | 2010 | 387 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2014 | 9185 | 0.150 |
Why?
|
| Intestine, Small | 3 | 2017 | 1243 | 0.140 |
Why?
|
| Vision Tests | 1 | 2017 | 167 | 0.140 |
Why?
|
| Syndrome | 4 | 2007 | 3248 | 0.140 |
Why?
|
| Retinal Neurons | 1 | 2016 | 65 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1997 | 323 | 0.140 |
Why?
|
| Algorithms | 4 | 2013 | 13853 | 0.140 |
Why?
|
| Gene Expression Profiling | 4 | 2009 | 9410 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2014 | 1860 | 0.140 |
Why?
|
| Colectomy | 3 | 2020 | 681 | 0.140 |
Why?
|
| Time Factors | 11 | 2021 | 40054 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2010 | 644 | 0.140 |
Why?
|
| Ligases | 1 | 1997 | 332 | 0.140 |
Why?
|
| DNA Repair-Deficiency Disorders | 1 | 2016 | 29 | 0.140 |
Why?
|
| Pedigree | 7 | 2016 | 4646 | 0.140 |
Why?
|
| Neoplasm Proteins | 4 | 2016 | 3691 | 0.140 |
Why?
|
| Alternative Splicing | 1 | 2021 | 1118 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2021 | 895 | 0.130 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 459 | 0.130 |
Why?
|
| Colonic Diseases | 1 | 2017 | 202 | 0.130 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2009 | 320 | 0.130 |
Why?
|
| Transgenes | 3 | 2015 | 1009 | 0.130 |
Why?
|
| HCT116 Cells | 1 | 2016 | 408 | 0.130 |
Why?
|
| Smad2 Protein | 2 | 2009 | 156 | 0.130 |
Why?
|
| Gene Deletion | 3 | 1998 | 2751 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4751 | 0.130 |
Why?
|
| Ventricular Function | 1 | 1997 | 416 | 0.130 |
Why?
|
| Age of Onset | 3 | 2018 | 3266 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 4 | 2008 | 6313 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 3920 | 0.130 |
Why?
|
| Anticarcinogenic Agents | 1 | 2017 | 253 | 0.130 |
Why?
|
| Zebrafish Proteins | 1 | 2001 | 1004 | 0.130 |
Why?
|
| Mice | 25 | 2021 | 81045 | 0.120 |
Why?
|
| Sp1 Transcription Factor | 1 | 1995 | 144 | 0.120 |
Why?
|
| Vegetables | 1 | 2020 | 1179 | 0.120 |
Why?
|
| Colon, Ascending | 1 | 2014 | 16 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 7276 | 0.120 |
Why?
|
| Hepatitis B | 2 | 1991 | 695 | 0.120 |
Why?
|
| Occipital Lobe | 1 | 2016 | 380 | 0.120 |
Why?
|
| Apoptosis | 2 | 2010 | 9715 | 0.120 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2014 | 74 | 0.120 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 2 | 2007 | 46 | 0.120 |
Why?
|
| Neoplasm Transplantation | 2 | 2009 | 2085 | 0.120 |
Why?
|
| Organogenesis | 1 | 2015 | 222 | 0.120 |
Why?
|
| Hedgehog Proteins | 2 | 2010 | 781 | 0.120 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2008 | 325 | 0.120 |
Why?
|
| Sensitivity and Specificity | 3 | 2024 | 14720 | 0.120 |
Why?
|
| Antineoplastic Agents | 5 | 2013 | 13655 | 0.120 |
Why?
|
| Eye Movements | 3 | 2013 | 506 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2016 | 433 | 0.120 |
Why?
|
| Hyperplasia | 2 | 2009 | 1183 | 0.120 |
Why?
|
| Thoracoscopy | 1 | 1994 | 178 | 0.120 |
Why?
|
| Immunomagnetic Separation | 1 | 2013 | 80 | 0.120 |
Why?
|
| DNA Mutational Analysis | 8 | 2007 | 4187 | 0.120 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2016 | 302 | 0.120 |
Why?
|
| Automation, Laboratory | 1 | 2013 | 101 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2009 | 5180 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2017 | 780 | 0.110 |
Why?
|
| Trans-Activators | 5 | 2019 | 2924 | 0.110 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 438 | 0.110 |
Why?
|
| Blinking | 1 | 2013 | 138 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2014 | 318 | 0.110 |
Why?
|
| Internationality | 1 | 2018 | 1002 | 0.110 |
Why?
|
| Cell Cycle Proteins | 4 | 2016 | 3444 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 322 | 0.110 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2012 | 33 | 0.110 |
Why?
|
| Child | 16 | 2021 | 77478 | 0.110 |
Why?
|
| Injections, Intramuscular | 2 | 1991 | 548 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 1337 | 0.110 |
Why?
|
| Optics and Photonics | 1 | 2014 | 321 | 0.110 |
Why?
|
| Pericardium | 1 | 1997 | 667 | 0.110 |
Why?
|
| Autoantibodies | 1 | 2021 | 2036 | 0.110 |
Why?
|
| Head Movements | 1 | 2013 | 150 | 0.110 |
Why?
|
| Angiopoietin-1 | 2 | 2010 | 114 | 0.110 |
Why?
|
| Retinal Bipolar Cells | 1 | 2012 | 47 | 0.110 |
Why?
|
| Chromosome Segregation | 1 | 2014 | 236 | 0.110 |
Why?
|
| DNA Replication | 2 | 2014 | 1397 | 0.110 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 2 | 2009 | 46 | 0.110 |
Why?
|
| Genes, BRCA2 | 1 | 2015 | 617 | 0.100 |
Why?
|
| Fusobacterium nucleatum | 1 | 2013 | 160 | 0.100 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 246 | 0.100 |
Why?
|
| Chromones | 1 | 2012 | 154 | 0.100 |
Why?
|
| Retrospective Studies | 10 | 2018 | 77098 | 0.100 |
Why?
|
| Disease Progression | 7 | 2019 | 13256 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 2 | 2015 | 2088 | 0.100 |
Why?
|
| Heart Conduction System | 2 | 2015 | 1048 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2012 | 494 | 0.100 |
Why?
|
| von Hippel-Lindau Disease | 2 | 2007 | 152 | 0.100 |
Why?
|
| Bacteriophages | 1 | 2015 | 354 | 0.100 |
Why?
|
| Models, Cardiovascular | 1 | 1997 | 994 | 0.100 |
Why?
|
| Esophageal Neoplasms | 2 | 2019 | 1581 | 0.100 |
Why?
|
| Microphthalmos | 2 | 2015 | 54 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2276 | 0.100 |
Why?
|
| HeLa Cells | 4 | 2013 | 3127 | 0.100 |
Why?
|
| Microsatellite Repeats | 3 | 2005 | 800 | 0.100 |
Why?
|
| Cytokines | 4 | 2021 | 7317 | 0.100 |
Why?
|
| Myelin Proteins | 1 | 2012 | 215 | 0.100 |
Why?
|
| RNA, Messenger | 8 | 2010 | 13029 | 0.100 |
Why?
|
| Child, Preschool | 7 | 2021 | 40955 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2014 | 2968 | 0.100 |
Why?
|
| Colitis | 1 | 2019 | 1149 | 0.100 |
Why?
|
| Risk Assessment | 6 | 2020 | 23320 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 3 | 2016 | 1363 | 0.100 |
Why?
|
| Microwaves | 1 | 2012 | 191 | 0.100 |
Why?
|
| Bacteroidetes | 2 | 2021 | 82 | 0.100 |
Why?
|
| Gene Silencing | 2 | 2007 | 1538 | 0.100 |
Why?
|
| beta Catenin | 3 | 2013 | 1058 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 3 | 2021 | 4465 | 0.100 |
Why?
|
| Esophagectomy | 1 | 1994 | 447 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 508 | 0.090 |
Why?
|
| Cathepsin B | 1 | 2010 | 82 | 0.090 |
Why?
|
| Diagnosis, Differential | 6 | 2019 | 12958 | 0.090 |
Why?
|
| Cross-Sectional Studies | 9 | 2020 | 24913 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2005 | 6249 | 0.090 |
Why?
|
| Phenotype | 7 | 2016 | 16331 | 0.090 |
Why?
|
| Chemokine CXCL12 | 2 | 2009 | 462 | 0.090 |
Why?
|
| Flavonoids | 2 | 2012 | 443 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 3915 | 0.090 |
Why?
|
| Chemokine CXCL6 | 1 | 2009 | 13 | 0.090 |
Why?
|
| Computers | 2 | 2023 | 611 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 2906 | 0.090 |
Why?
|
| Primary Health Care | 2 | 2016 | 4551 | 0.090 |
Why?
|
| Endoscopy | 1 | 2020 | 1774 | 0.090 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 890 | 0.090 |
Why?
|
| Prospective Studies | 8 | 2022 | 53187 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 749 | 0.090 |
Why?
|
| Neuropilin-1 | 1 | 2009 | 90 | 0.090 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 39004 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2016 | 1059 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 10943 | 0.090 |
Why?
|
| Dogs | 4 | 2022 | 3910 | 0.080 |
Why?
|
| Hepatitis D | 1 | 1988 | 18 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 2699 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 6 | 2010 | 9274 | 0.080 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2013 | 428 | 0.080 |
Why?
|
| Cell Dedifferentiation | 1 | 2009 | 135 | 0.080 |
Why?
|
| Morpholines | 1 | 2012 | 561 | 0.080 |
Why?
|
| Treatment Outcome | 13 | 2021 | 62966 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2007 | 2842 | 0.080 |
Why?
|
| Gene Expression | 5 | 2014 | 7790 | 0.080 |
Why?
|
| Synapses | 2 | 2021 | 1724 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 1158 | 0.080 |
Why?
|
| DNA, Complementary | 4 | 2022 | 2049 | 0.080 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 314 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2014 | 861 | 0.080 |
Why?
|
| Sulfonamides | 2 | 2009 | 1932 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2009 | 438 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 2 | 2009 | 1799 | 0.080 |
Why?
|
| Antigens, CD | 5 | 2012 | 4024 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2013 | 3557 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 1983 | 0.080 |
Why?
|
| Risk Factors | 15 | 2021 | 72145 | 0.080 |
Why?
|
| Microfluidics | 1 | 2013 | 662 | 0.080 |
Why?
|
| Iatrogenic Disease | 1 | 1991 | 545 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 3639 | 0.080 |
Why?
|
| RNA Interference | 1 | 2016 | 2890 | 0.080 |
Why?
|
| Extracellular Matrix | 3 | 2021 | 1740 | 0.080 |
Why?
|
| Adenoma, Villous | 2 | 2005 | 15 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2012 | 3800 | 0.080 |
Why?
|
| Polymers | 1 | 2015 | 1618 | 0.080 |
Why?
|
| Umbilical Veins | 1 | 2008 | 433 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 4801 | 0.070 |
Why?
|
| Pyrazoles | 2 | 2009 | 1970 | 0.070 |
Why?
|
| Stem Cells | 4 | 2014 | 3563 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 1541 | 0.070 |
Why?
|
| Prevalence | 6 | 2020 | 15194 | 0.070 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 2007 | 44 | 0.070 |
Why?
|
| Heartburn | 1 | 2007 | 68 | 0.070 |
Why?
|
| Anesthesia, General | 1 | 1994 | 1164 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2009 | 3612 | 0.070 |
Why?
|
| Vesicular Transport Proteins | 1 | 2010 | 377 | 0.070 |
Why?
|
| Respiration | 3 | 2007 | 1645 | 0.070 |
Why?
|
| Catheter Ablation | 2 | 2012 | 2746 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2020 | 3527 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 1 | 2008 | 317 | 0.070 |
Why?
|
| Founder Effect | 1 | 2007 | 190 | 0.070 |
Why?
|
| Natural Language Processing | 1 | 2015 | 1035 | 0.070 |
Why?
|
| Aneuploidy | 1 | 2010 | 530 | 0.070 |
Why?
|
| Carcinoma in Situ | 1 | 2012 | 802 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2018 | 2235 | 0.070 |
Why?
|
| Contracture | 1 | 1989 | 223 | 0.070 |
Why?
|
| Dyspepsia | 1 | 2007 | 114 | 0.070 |
Why?
|
| Health Personnel | 1 | 2020 | 3210 | 0.070 |
Why?
|
| Intestinal Polyps | 2 | 2005 | 99 | 0.070 |
Why?
|
| Models, Biological | 3 | 2007 | 9581 | 0.070 |
Why?
|
| Hydrogen Peroxide | 2 | 2010 | 730 | 0.070 |
Why?
|
| Liver Neoplasms | 3 | 2009 | 4249 | 0.070 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2009 | 503 | 0.070 |
Why?
|
| Models, Theoretical | 2 | 2015 | 3584 | 0.070 |
Why?
|
| Neoplasms | 3 | 2007 | 21596 | 0.070 |
Why?
|
| Insulinoma | 2 | 1997 | 124 | 0.070 |
Why?
|
| Neoadjuvant Therapy | 4 | 2011 | 2721 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2016 | 2266 | 0.070 |
Why?
|
| Genomics | 2 | 2014 | 5692 | 0.070 |
Why?
|
| Cell Line | 6 | 2014 | 15994 | 0.070 |
Why?
|
| Polymorphism, Genetic | 4 | 2010 | 4328 | 0.070 |
Why?
|
| HT29 Cells | 1 | 2005 | 200 | 0.070 |
Why?
|
| Renin-Angiotensin System | 1 | 2010 | 759 | 0.070 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2005 | 25 | 0.070 |
Why?
|
| Intestinal Polyposis | 1 | 2005 | 44 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4200 | 0.070 |
Why?
|
| Cell Cycle | 3 | 2013 | 2964 | 0.070 |
Why?
|
| Lens Diseases | 1 | 2005 | 13 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2009 | 1096 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 1374 | 0.060 |
Why?
|
| Genome | 1 | 2014 | 1803 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 2763 | 0.060 |
Why?
|
| Gastric Mucosa | 3 | 2014 | 598 | 0.060 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2005 | 43 | 0.060 |
Why?
|
| RNA, Neoplasm | 1 | 2008 | 768 | 0.060 |
Why?
|
| TCF Transcription Factors | 1 | 2005 | 140 | 0.060 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2005 | 154 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2013 | 1175 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2007 | 457 | 0.060 |
Why?
|
| SEER Program | 3 | 2017 | 1507 | 0.060 |
Why?
|
| Amniotic Fluid | 1 | 2007 | 366 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2007 | 458 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 726 | 0.060 |
Why?
|
| Chromosomes, Human, X | 1 | 2006 | 296 | 0.060 |
Why?
|
| DNA | 4 | 2014 | 7289 | 0.060 |
Why?
|
| Fluorescein Angiography | 2 | 2022 | 936 | 0.060 |
Why?
|
| rho-Associated Kinases | 1 | 2006 | 279 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2012 | 3001 | 0.060 |
Why?
|
| Sensory Thresholds | 2 | 2019 | 394 | 0.060 |
Why?
|
| Smad4 Protein | 2 | 2005 | 163 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 19862 | 0.060 |
Why?
|
| Lentivirus | 1 | 2007 | 501 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2006 | 376 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2016 | 5163 | 0.060 |
Why?
|
| Barrett Esophagus | 1 | 2008 | 494 | 0.060 |
Why?
|
| Ophthalmoscopy | 3 | 2014 | 176 | 0.060 |
Why?
|
| Fetal Blood | 2 | 2005 | 1317 | 0.060 |
Why?
|
| Muscles | 1 | 1989 | 1617 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2012 | 7721 | 0.060 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2005 | 139 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2016 | 18006 | 0.060 |
Why?
|
| Gastric Fundus | 2 | 2014 | 39 | 0.060 |
Why?
|
| Color | 1 | 2005 | 306 | 0.060 |
Why?
|
| RNA | 1 | 2014 | 2747 | 0.060 |
Why?
|
| Radiotherapy Dosage | 2 | 2007 | 2876 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 2 | 2002 | 2006 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1998 | 3123 | 0.060 |
Why?
|
| Descemet Membrane | 1 | 2003 | 42 | 0.060 |
Why?
|
| Informed Consent | 1 | 2010 | 991 | 0.060 |
Why?
|
| Corneal Opacity | 1 | 2003 | 59 | 0.060 |
Why?
|
| Cohort Studies | 8 | 2021 | 40450 | 0.060 |
Why?
|
| Exotropia | 1 | 2003 | 55 | 0.060 |
Why?
|
| Reperfusion Injury | 1 | 2010 | 1025 | 0.060 |
Why?
|
| Visual Cortex | 1 | 2011 | 1149 | 0.060 |
Why?
|
| Serpins | 1 | 2004 | 247 | 0.060 |
Why?
|
| Prognosis | 9 | 2015 | 29010 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2007 | 1692 | 0.050 |
Why?
|
| Retinitis Pigmentosa | 1 | 2006 | 386 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2021 | 21719 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 1525 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2017 | 10248 | 0.050 |
Why?
|
| Blepharoptosis | 1 | 2003 | 144 | 0.050 |
Why?
|
| Alleles | 3 | 1998 | 6931 | 0.050 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2007 | 1093 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2006 | 370 | 0.050 |
Why?
|
| Iris | 1 | 2003 | 239 | 0.050 |
Why?
|
| Base Sequence | 4 | 2006 | 12797 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2005 | 493 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2010 | 1376 | 0.050 |
Why?
|
| Cell Adhesion | 2 | 1990 | 3139 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2013 | 21821 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 2513 | 0.050 |
Why?
|
| Fibrosis | 3 | 2021 | 2026 | 0.050 |
Why?
|
| Membrane Proteins | 3 | 2014 | 7873 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2007 | 587 | 0.050 |
Why?
|
| Disclosure | 1 | 2008 | 736 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3081 | 0.050 |
Why?
|
| CA-19-9 Antigen | 1 | 2022 | 111 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2005 | 1150 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 2014 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2008 | 2455 | 0.050 |
Why?
|
| Rectum | 1 | 2006 | 903 | 0.050 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2021 | 43 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2004 | 576 | 0.050 |
Why?
|
| Survival Rate | 4 | 2008 | 12773 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2007 | 2295 | 0.050 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2001 | 113 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 1640 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2007 | 877 | 0.050 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2000 | 25 | 0.050 |
Why?
|
| Exercise | 1 | 2017 | 5611 | 0.050 |
Why?
|
| Wakefulness | 1 | 1988 | 1243 | 0.050 |
Why?
|
| Actinobacteria | 1 | 2021 | 56 | 0.050 |
Why?
|
| Eye Abnormalities | 1 | 2003 | 246 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 3504 | 0.050 |
Why?
|
| United States | 8 | 2018 | 69693 | 0.050 |
Why?
|
| Age Distribution | 1 | 2007 | 2900 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2021 | 112 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11472 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 4379 | 0.050 |
Why?
|
| Dynamins | 1 | 2021 | 152 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2006 | 18112 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2001 | 378 | 0.050 |
Why?
|
| Pigment Epithelium of Eye | 2 | 2002 | 220 | 0.050 |
Why?
|
| Oculomotor Muscles | 1 | 2003 | 371 | 0.040 |
Why?
|
| Cataract | 1 | 2006 | 833 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 20774 | 0.040 |
Why?
|
| Graft Survival | 1 | 2010 | 3733 | 0.040 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1988 | 941 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2001 | 772 | 0.040 |
Why?
|
| Androstadienes | 1 | 2001 | 346 | 0.040 |
Why?
|
| Veratrum Alkaloids | 2 | 2010 | 25 | 0.040 |
Why?
|
| Disease Management | 1 | 2010 | 2450 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2010 | 11001 | 0.040 |
Why?
|
| Anesthesia, Local | 1 | 2001 | 268 | 0.040 |
Why?
|
| Oxygen | 3 | 2010 | 4169 | 0.040 |
Why?
|
| Retinal Vessels | 1 | 2004 | 769 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2021 | 437 | 0.040 |
Why?
|
| Patient Selection | 1 | 2011 | 4214 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 3038 | 0.040 |
Why?
|
| Pyramidal Cells | 1 | 2021 | 363 | 0.040 |
Why?
|
| Immunochemistry | 1 | 2018 | 124 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 35342 | 0.040 |
Why?
|
| Septins | 1 | 2018 | 54 | 0.040 |
Why?
|
| Jews | 1 | 2000 | 385 | 0.040 |
Why?
|
| Radiography | 2 | 2006 | 7010 | 0.040 |
Why?
|
| Lidocaine | 1 | 2001 | 542 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2008 | 4455 | 0.040 |
Why?
|
| Gastrinoma | 1 | 1997 | 21 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 849 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2001 | 670 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2007 | 2556 | 0.040 |
Why?
|
| Mice, Knockout | 4 | 2015 | 14554 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 1675 | 0.040 |
Why?
|
| Occult Blood | 1 | 2018 | 176 | 0.040 |
Why?
|
| Hypoglycemia | 1 | 2005 | 859 | 0.040 |
Why?
|
| Taiwan | 2 | 1989 | 496 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1998 | 351 | 0.040 |
Why?
|
| Cell Movement | 1 | 2009 | 5212 | 0.040 |
Why?
|
| Serine | 1 | 2021 | 828 | 0.040 |
Why?
|
| Lung Neoplasms | 3 | 2012 | 13019 | 0.040 |
Why?
|
| Laminin | 2 | 1990 | 418 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 9735 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1998 | 417 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2005 | 3493 | 0.040 |
Why?
|
| Vision, Low | 1 | 2019 | 168 | 0.040 |
Why?
|
| Genetics | 1 | 2017 | 112 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 1988 | 4839 | 0.040 |
Why?
|
| Organoplatinum Compounds | 1 | 2018 | 408 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1998 | 355 | 0.040 |
Why?
|
| Leucovorin | 1 | 2018 | 624 | 0.040 |
Why?
|
| Family | 1 | 2008 | 3144 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 1997 | 803 | 0.040 |
Why?
|
| Age Factors | 5 | 2018 | 18355 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 983 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2020 | 12017 | 0.040 |
Why?
|
| Metagenomics | 1 | 2020 | 430 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1995 | 708 | 0.040 |
Why?
|
| Safety | 2 | 2013 | 1185 | 0.040 |
Why?
|
| Infant | 1 | 2018 | 35070 | 0.040 |
Why?
|
| Species Specificity | 1 | 2021 | 2479 | 0.040 |
Why?
|
| Interneurons | 1 | 2021 | 576 | 0.040 |
Why?
|
| Ornithine-Oxo-Acid Transaminase | 1 | 1996 | 48 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 947 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 768 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 12242 | 0.030 |
Why?
|
| Prostaglandins | 1 | 2017 | 405 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2001 | 860 | 0.030 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 1997 | 290 | 0.030 |
Why?
|
| Blood Volume | 1 | 1997 | 565 | 0.030 |
Why?
|
| Diet | 2 | 2020 | 7923 | 0.030 |
Why?
|
| Lod Score | 2 | 2006 | 615 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 1617 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2016 | 179 | 0.030 |
Why?
|
| Thymine | 1 | 1995 | 68 | 0.030 |
Why?
|
| Fibronectins | 2 | 1990 | 723 | 0.030 |
Why?
|
| Injections | 2 | 2009 | 840 | 0.030 |
Why?
|
| Photic Stimulation | 2 | 2012 | 2027 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 209 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 12705 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 4246 | 0.030 |
Why?
|
| Cellular Structures | 1 | 2014 | 11 | 0.030 |
Why?
|
| Macular Degeneration | 1 | 2002 | 980 | 0.030 |
Why?
|
| Ophthalmoscopes | 1 | 2014 | 23 | 0.030 |
Why?
|
| Intussusception | 1 | 2016 | 115 | 0.030 |
Why?
|
| Markov Chains | 2 | 2009 | 969 | 0.030 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2016 | 195 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 15056 | 0.030 |
Why?
|
| Fruit | 1 | 2020 | 1139 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 604 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2005 | 4143 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2001 | 984 | 0.030 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2016 | 213 | 0.030 |
Why?
|
| Insufflation | 1 | 1994 | 65 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 257 | 0.030 |
Why?
|
| Blood Buffy Coat | 1 | 2013 | 11 | 0.030 |
Why?
|
| Kidney | 1 | 2010 | 7167 | 0.030 |
Why?
|
| Gene Order | 1 | 2014 | 176 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1997 | 4322 | 0.030 |
Why?
|
| Pressure | 1 | 1997 | 1203 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 7901 | 0.030 |
Why?
|
| Boston | 2 | 2017 | 9305 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2014 | 225 | 0.030 |
Why?
|
| Centrifugation | 1 | 2013 | 122 | 0.030 |
Why?
|
| Pleural Diseases | 1 | 1994 | 139 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 2014 | 472 | 0.030 |
Why?
|
| Fetal Monitoring | 1 | 1993 | 70 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1994 | 235 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2008 | 11470 | 0.030 |
Why?
|
| Telomere | 1 | 2019 | 909 | 0.030 |
Why?
|
| Community Health Centers | 1 | 2016 | 428 | 0.030 |
Why?
|
| Consanguinity | 2 | 2006 | 456 | 0.030 |
Why?
|
| Rats | 3 | 2021 | 24265 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2013 | 365 | 0.030 |
Why?
|
| Cardia | 1 | 2012 | 57 | 0.030 |
Why?
|
| Dissection | 1 | 1994 | 294 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 13921 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2008 | 3306 | 0.030 |
Why?
|
| Thoracotomy | 1 | 1994 | 363 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2001 | 4029 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2016 | 783 | 0.030 |
Why?
|
| Cells, Cultured | 5 | 2014 | 19223 | 0.030 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2012 | 93 | 0.030 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2012 | 150 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2018 | 1679 | 0.030 |
Why?
|
| Sleep | 1 | 1988 | 4604 | 0.030 |
Why?
|
| Propionates | 1 | 2012 | 168 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2018 | 5385 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 2410 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2012 | 100 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2002 | 2948 | 0.030 |
Why?
|
| Risk | 2 | 2015 | 9679 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2014 | 15244 | 0.030 |
Why?
|
| Malpractice | 1 | 2016 | 569 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2012 | 140 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 6608 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 576 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2013 | 246 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 1179 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2016 | 907 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 794 | 0.020 |
Why?
|
| Aging | 2 | 2005 | 8626 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 689 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 865 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2011 | 3770 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 913 | 0.020 |
Why?
|
| Mutagenesis | 1 | 1995 | 1263 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2019 | 1895 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2017 | 1905 | 0.020 |
Why?
|
| Homozygote | 2 | 2006 | 1777 | 0.020 |
Why?
|
| Sensory Deprivation | 1 | 2011 | 109 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1459 | 0.020 |
Why?
|
| Drug Costs | 1 | 2018 | 1104 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15494 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2007 | 4823 | 0.020 |
Why?
|
| Microspheres | 1 | 2013 | 777 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2012 | 212 | 0.020 |
Why?
|
| Population Surveillance | 2 | 2012 | 2616 | 0.020 |
Why?
|
| Genetic Linkage | 2 | 2006 | 2422 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 713 | 0.020 |
Why?
|
| Lung Diseases | 2 | 2005 | 1884 | 0.020 |
Why?
|
| Collagen | 2 | 1990 | 2684 | 0.020 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2010 | 87 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1994 | 656 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2019 | 2504 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1994 | 1141 | 0.020 |
Why?
|
| Physical Examination | 1 | 2016 | 1239 | 0.020 |
Why?
|
| Nystagmus, Physiologic | 1 | 2009 | 29 | 0.020 |
Why?
|
| Haplotypes | 2 | 2007 | 2781 | 0.020 |
Why?
|
| Exons | 1 | 2016 | 2431 | 0.020 |
Why?
|
| Angiogenic Proteins | 1 | 2010 | 104 | 0.020 |
Why?
|
| Butadienes | 1 | 2010 | 110 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 905 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 963 | 0.020 |
Why?
|
| Biopsy | 2 | 2012 | 6756 | 0.020 |
Why?
|
| Oximetry | 1 | 1993 | 467 | 0.020 |
Why?
|
| Adenine | 1 | 1995 | 936 | 0.020 |
Why?
|
| Oncogenes | 1 | 1995 | 1263 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 400 | 0.020 |
Why?
|
| Hip Contracture | 1 | 1989 | 3 | 0.020 |
Why?
|
| Dendrites | 1 | 2012 | 485 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 164 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 718 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2007 | 1547 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12344 | 0.020 |
Why?
|
| Primates | 1 | 2012 | 543 | 0.020 |
Why?
|
| Nephritis, Interstitial | 1 | 2010 | 156 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2012 | 497 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2012 | 1135 | 0.020 |
Why?
|
| Motor Activity | 1 | 2019 | 2714 | 0.020 |
Why?
|
| Hepatitis Antibodies | 1 | 1988 | 73 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 2009 | 219 | 0.020 |
Why?
|
| Phosphorylation | 3 | 2010 | 8436 | 0.020 |
Why?
|
| Epithelium | 2 | 2010 | 1680 | 0.020 |
Why?
|
| Decision Trees | 1 | 2010 | 506 | 0.020 |
Why?
|
| Fever | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2008 | 60 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1990 | 417 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2012 | 565 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1889 | 0.020 |
Why?
|
| Newfoundland and Labrador | 1 | 2007 | 12 | 0.020 |
Why?
|
| Permeability | 1 | 2010 | 738 | 0.020 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1988 | 305 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 1994 | 1188 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2008 | 281 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 1988 | 0.020 |
Why?
|
| Moral Obligations | 1 | 2008 | 96 | 0.020 |
Why?
|
| Atrioventricular Node | 1 | 1988 | 182 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2012 | 1770 | 0.020 |
Why?
|
| Lactose | 1 | 2007 | 95 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2013 | 3014 | 0.020 |
Why?
|
| Shoulder | 1 | 1989 | 299 | 0.020 |
Why?
|
| Heparitin Sulfate | 1 | 1988 | 225 | 0.020 |
Why?
|
| Serologic Tests | 1 | 1988 | 374 | 0.020 |
Why?
|
| Dermis | 1 | 2008 | 207 | 0.020 |
Why?
|
| Periodicity | 1 | 1988 | 363 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2012 | 927 | 0.020 |
Why?
|
| Hydrogen | 1 | 2007 | 164 | 0.020 |
Why?
|
| Pregnancy | 2 | 2007 | 29087 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2018 | 3740 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 1994 | 1357 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3582 | 0.020 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 2005 | 8 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 15108 | 0.020 |
Why?
|
| Linear Models | 1 | 2016 | 5948 | 0.020 |
Why?
|
| Azacitidine | 1 | 2007 | 347 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1993 | 1354 | 0.020 |
Why?
|
| Somatostatin | 1 | 2008 | 459 | 0.020 |
Why?
|
| Gene Library | 2 | 2002 | 1076 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2010 | 727 | 0.020 |
Why?
|
| CpG Islands | 1 | 2010 | 1170 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2011 | 1769 | 0.020 |
Why?
|
| DNA Damage | 1 | 1995 | 2423 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 1915 | 0.020 |
Why?
|
| Penetrance | 1 | 2007 | 380 | 0.020 |
Why?
|
| Lebanon | 1 | 2006 | 227 | 0.020 |
Why?
|
| Tachycardia | 1 | 1988 | 620 | 0.020 |
Why?
|
| Proctoscopy | 1 | 2005 | 42 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2006 | 287 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2009 | 8621 | 0.020 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2007 | 169 | 0.020 |
Why?
|
| Leukocytes | 1 | 2013 | 2039 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 1095 | 0.020 |
Why?
|
| Sleep, REM | 1 | 1988 | 594 | 0.020 |
Why?
|
| Epistaxis | 1 | 2005 | 111 | 0.020 |
Why?
|
| Sex Factors | 2 | 1989 | 10392 | 0.020 |
Why?
|
| Africa | 1 | 2007 | 670 | 0.020 |
Why?
|
| Communication Barriers | 1 | 2008 | 398 | 0.020 |
Why?
|
| Nitriles | 1 | 2010 | 952 | 0.020 |
Why?
|
| Logistic Models | 2 | 2010 | 13403 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2013 | 2231 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 3 | 2003 | 6171 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2007 | 644 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 1916 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3611 | 0.010 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2010 | 859 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2008 | 704 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1988 | 846 | 0.010 |
Why?
|
| Molecular Biology | 1 | 2008 | 595 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 1912 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 2505 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2007 | 610 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3701 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 1994 | 2566 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2008 | 1184 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2005 | 891 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 466 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2016 | 2301 | 0.010 |
Why?
|
| Protein Binding | 1 | 1995 | 9387 | 0.010 |
Why?
|
| Catheterization | 1 | 2008 | 1468 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20086 | 0.010 |
Why?
|
| Interdisciplinary Communication | 1 | 2008 | 950 | 0.010 |
Why?
|
| Ophthalmoplegia | 1 | 2003 | 166 | 0.010 |
Why?
|
| Retinal Drusen | 1 | 2002 | 66 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7770 | 0.010 |
Why?
|
| Arteriovenous Malformations | 1 | 2005 | 396 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2015 | 6440 | 0.010 |
Why?
|
| Smad3 Protein | 1 | 2002 | 180 | 0.010 |
Why?
|
| Proteins | 1 | 1997 | 6096 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2015 | 6191 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2970 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 1866 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2005 | 880 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3471 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 829 | 0.010 |
Why?
|
| Absorption | 1 | 2001 | 248 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 2906 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 9941 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 2382 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2723 | 0.010 |
Why?
|
| Manometry | 1 | 2003 | 444 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2001 | 191 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2010 | 2128 | 0.010 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2010 | 1162 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 5979 | 0.010 |
Why?
|
| Iran | 1 | 2003 | 704 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2011 | 2924 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2005 | 1400 | 0.010 |
Why?
|
| Optic Disk | 1 | 2004 | 401 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 1707 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 595 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 385 | 0.010 |
Why?
|
| Binding Sites | 1 | 2009 | 6115 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2013 | 3203 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1520 | 0.010 |
Why?
|
| Kinetics | 1 | 1988 | 6474 | 0.010 |
Why?
|
| Incidence | 2 | 2008 | 20928 | 0.010 |
Why?
|
| Cell Division | 2 | 2002 | 4564 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 6891 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6534 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 1160 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 3923 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2009 | 3199 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 1683 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2723 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1990 | 3769 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1988 | 6365 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2010 | 5522 | 0.010 |
Why?
|
| Protein Folding | 1 | 2002 | 843 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1969 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 2867 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2006 | 1167 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 6382 | 0.010 |
Why?
|
| Social Support | 1 | 2007 | 2117 | 0.010 |
Why?
|
| Motivation | 1 | 2007 | 1968 | 0.010 |
Why?
|
| Smoking | 1 | 1994 | 8969 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3862 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2005 | 1252 | 0.010 |
Why?
|
| Tyrosine | 1 | 2001 | 1460 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2007 | 1952 | 0.010 |
Why?
|
| Luciferases | 1 | 1998 | 733 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2009 | 3455 | 0.010 |
Why?
|
| Defective Viruses | 1 | 1996 | 112 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6483 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 5133 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 647 | 0.010 |
Why?
|
| Trachea | 1 | 2001 | 1075 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1996 | 146 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3617 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2001 | 2638 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2145 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2010 | 7716 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8297 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2009 | 5100 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 2459 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 3215 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1996 | 442 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1801 | 0.010 |
Why?
|
| Janus Kinase 1 | 1 | 1993 | 104 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1988 | 6142 | 0.010 |
Why?
|
| DNA Primers | 1 | 1996 | 2892 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 1213 | 0.010 |
Why?
|
| Heymann Nephritis Antigenic Complex | 1 | 1990 | 16 | 0.010 |
Why?
|
| Sheep | 1 | 1993 | 1437 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15530 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2191 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 2837 | 0.010 |
Why?
|
| Quality of Life | 1 | 2009 | 12730 | 0.000 |
Why?
|
| Head and Neck Neoplasms | 1 | 2001 | 2712 | 0.000 |
Why?
|
| HIV Infections | 1 | 2013 | 16678 | 0.000 |
Why?
|
| Brain | 1 | 1993 | 26343 | 0.000 |
Why?
|
| Tidal Volume | 1 | 1988 | 489 | 0.000 |
Why?
|
| Integrins | 1 | 1990 | 845 | 0.000 |
Why?
|
| Sleep Stages | 1 | 1988 | 686 | 0.000 |
Why?
|
| Epitopes | 1 | 1990 | 2569 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1993 | 5062 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2003 | 25575 | 0.000 |
Why?
|
| Mitochondria | 1 | 1996 | 3520 | 0.000 |
Why?
|
| Glycoproteins | 1 | 1990 | 2260 | 0.000 |
Why?
|
| Esophagus | 1 | 1988 | 1017 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1993 | 13814 | 0.000 |
Why?
|